Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?


Journal

Movement disorders : official journal of the Movement Disorder Society
ISSN: 1531-8257
Titre abrégé: Mov Disord
Pays: United States
ID NLM: 8610688

Informations de publication

Date de publication:
09 2020
Historique:
received: 24 01 2020
revised: 30 04 2020
accepted: 04 05 2020
pubmed: 11 6 2020
medline: 28 4 2021
entrez: 11 6 2020
Statut: ppublish

Résumé

The objective of this study was to determine the frequency and impact of subjective cognitive complaint (SCC) in Parkinson's disease (PD) patients with normal cognition. Patients with PD with expert consensus-determined normal cognition at baseline were asked a single question regarding the presence of SCC. Baseline (N = 153) and longitudinal (up to 4 follow-up visits during a 5-year period; N = 121) between-group differences in patients with PD with (+SCC) and without (-SCC) cognitive complaint were examined, including cognitive test performance and self-rated and informant-rated functional abilities. A total of 81 (53%) participants reported a cognitive complaint. There were no between-group differences in global cognition at baseline. Longitudinally, the +SCC group declined more than the -SCC group on global cognition (Mattis Dementia Rating Scale-2 total score, F Patients with PD with normal cognition, but with SCC, report poorer cognition-specific functional abilities, and are more likely to be diagnosed with cognitive impairment and experience global functional ability decline long term. These findings suggest that SCC and worse cognition-related functional abilities may be sensitive indicators of initial cognitive decline in PD. © 2020 International Parkinson and Movement Disorder Society.

Identifiants

pubmed: 32520435
doi: 10.1002/mds.28115
pmc: PMC7722141
mid: NIHMS1592004
doi:

Substances chimiques

Coal 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1618-1625

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS102324
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG010124
Pays : United States
Organisme : NINDS NIH HHS
ID : P50 NS053488
Pays : United States
Organisme : NIA NIH HHS
ID : U19 AG062418
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS097056
Pays : United States

Informations de copyright

© 2020 International Parkinson and Movement Disorder Society.

Références

Neurology. 2015 Oct 13;85(15):1276-82
pubmed: 26362285
J Int Neuropsychol Soc. 2003 Jan;9(1):17-24
pubmed: 12570354
Assessment. 1999 Jun;6(2):147-78
pubmed: 10335019
Mov Disord. 2009 Jul 15;24(9):1333-8
pubmed: 19425086
Eur Neurol. 1989;29(2):71-6
pubmed: 2707295
Neuropsychol Rev. 2016 Dec;26(4):376-393
pubmed: 27714573
J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
pubmed: 1564476
Acta Neurol Scand. 2018 Jan;137(1):59-66
pubmed: 28832893
J Clin Neurol. 2018 Jan;14(1):16-21
pubmed: 29141280
Int Psychogeriatr. 2015 Mar;27(3):357-66
pubmed: 25382659
Mov Disord. 2009 Dec 15;24(16):2391-7
pubmed: 19908317
Mov Disord. 2007 Sep 15;22(12):1689-707; quiz 1837
pubmed: 17542011
J Clin Epidemiol. 2001 Apr;54(4):343-9
pubmed: 11297884
Mov Disord. 2008 Apr 30;23(6):837-44
pubmed: 18307261
Parkinsons Dis. 2012;2012:793076
pubmed: 22203919
J Neurol. 2010 Jan;257(1):79-84
pubmed: 19690907
Brain. 2007 Jul;130(Pt 7):1787-98
pubmed: 17535834
Alzheimer Dis Assoc Disord. 2019 Apr-Jun;33(2):147-153
pubmed: 30958414
Mov Disord. 2011 Mar;26(4):644-52
pubmed: 21312275
Neurology. 1967 May;17(5):427-42
pubmed: 6067254
J Neural Transm (Vienna). 2019 Oct;126(10):1329-1335
pubmed: 31278557
Neuropsychology. 2014 Mar;28(2):229-37
pubmed: 24417192
Neurobiol Aging. 2014 Jul;35(7):1739-43
pubmed: 24507441
Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S33-9
pubmed: 9236950
J Parkinsons Dis. 2017;7(2):385-395
pubmed: 28387684
Arch Clin Neuropsychol. 2008 May;23(3):295-327
pubmed: 18243644
Parkinsonism Relat Disord. 2013 Sep;19(9):812-7
pubmed: 23773412
Acta Psychiatr Scand. 2014 Dec;130(6):439-51
pubmed: 25219393
Parkinsonism Relat Disord. 2016 Apr;25:21-6
pubmed: 26923524
J Neurol. 2019 Mar;266(3):745-754
pubmed: 30635723
Dement Geriatr Cogn Disord. 2006;22(5-6):471-85
pubmed: 17047326
Alzheimers Dement. 2013 Sep;9(5):609-14
pubmed: 23164549
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Arch Neurol. 1978 Jun;35(6):364-7
pubmed: 655909
J Geriatr Psychiatry Neurol. 2014 Dec;27(4):276-81
pubmed: 24789732
Neurology. 2010 Sep 21;75(12):1062-9
pubmed: 20855849
Int Psychogeriatr. 2008 Feb;20(1):1-16
pubmed: 18072981
Mov Disord. 2012 Mar;27(3):349-56
pubmed: 22275317
Parkinsonism Relat Disord. 2015 Aug;21(8):992-5
pubmed: 26117435
Eur J Neurol. 2014 Mar;21(3):541-4
pubmed: 23790130
Arch Gen Psychiatry. 2010 Apr;67(4):414-22
pubmed: 20368517

Auteurs

Rachael Purri (R)

Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.

Laura Brennan (L)

Department of Neurology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.

Jacqueline Rick (J)

Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.

Sharon X Xie (SX)

Department of Biostatistics, Epidemiology, & Informatics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.

Benjamin L Deck (BL)

Department of Psychology, Drexel University, Philadelphia, Pennsylvania, USA.

Lana M Chahine (LM)

Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Nabila Dahodwala (N)

Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.

Alice Chen-Plotkin (A)

Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.

John E Duda (JE)

Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Parkinson's Disease Research, Education, and Clinical Center, Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA.

James F Morley (JF)

Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Parkinson's Disease Research, Education, and Clinical Center, Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA.

Rizwan S Akhtar (RS)

Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.

John Q Trojanowski (JQ)

Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.

Andrew Siderowf (A)

Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.

Daniel Weintraub (D)

Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Parkinson's Disease Research, Education, and Clinical Center, Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA.
Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH